{"id":"NCT01185340","sponsor":"Eli Lilly and Company","briefTitle":"A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor","officialTitle":"A Randomized Placebo-Controlled, Double-Blind Study of LY2216684 Flexible-Dose 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-03","primaryCompletion":"2013-04","completion":"2013-04","firstPosted":"2010-08-19","resultsPosted":"2018-04-27","lastUpdate":"2018-04-27"},"enrollment":1056,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Major Depressive Disorder"],"interventions":[{"type":"DRUG","name":"LY2216684","otherNames":["Edivoxetine"]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"SSRI","otherNames":["selective serotonin reuptake inhibitor"]}],"arms":[{"label":"LY2216684 + SSRI","type":"EXPERIMENTAL"},{"label":"Placebo + SSRI","type":"PLACEBO_COMPARATOR"}],"summary":"The primary objective of this study is to assess whether LY2216684 12 milligrams (mg) or 18 mg flexible dose once daily is superior to placebo once daily in the adjunctive treatment of participants with major depressive disorder (MDD) who are partial responders to their selective serotonin reuptake inhibitor (SSRI) treatment.","primaryOutcome":{"measure":"Change From Randomization to Week 8 in Montgomery-Asberg Depression Rating Scale (MADRS) Total Score","timeFrame":"Randomization, 8 weeks","effectByArm":[{"arm":"LY2216684 + SSRI","deltaMin":-8.73,"sd":0.55},{"arm":"Placebo + SSRI","deltaMin":-8.49,"sd":0.57}],"pValues":[{"comp":"OG000 vs OG001","p":"0.751"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":12},"locations":{"siteCount":49,"countries":["United States","Australia","Austria","Belgium","Germany","Sweden","United Kingdom"]},"refs":{"pmids":["27685842","27035159"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":9,"n":1052},"commonTop":["Headache","Nausea","Nasopharyngitis","Hyperhidrosis","Dizziness"]}}